Clinical trial
Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth
NCT03344900 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 5, 2017
- Completion date
- June 28, 2018
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease